153 related articles for article (PubMed ID: 24379617)
1. Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients.
Mangia A; Mottola L; Santoro R
World J Gastroenterol; 2013 Dec; 19(47):8924-8. PubMed ID: 24379617
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.
de Castellarnau M; Aparicio E; Parera M; Franco S; Tural C; Clotet B; Martínez MA
PLoS One; 2012; 7(2):e31016. PubMed ID: 22328925
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
[TBL] [Abstract][Full Text] [Related]
6. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
[TBL] [Abstract][Full Text] [Related]
7. The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.
Bellanti F; Vendemiale G; Altomare E; Serviddio G
Clin Dev Immunol; 2012; 2012():849373. PubMed ID: 22966241
[TBL] [Abstract][Full Text] [Related]
8. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V
AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235
[TBL] [Abstract][Full Text] [Related]
9. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
Kobayashi M; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Chayama K; Miyakawa Y; Kumada H
J Gastroenterol; 2012 May; 47(5):596-605. PubMed ID: 22438096
[TBL] [Abstract][Full Text] [Related]
10. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR;
Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
12. Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.
Sticchi L; Di Biagio A; Rappazzo E; Setti M; De Rosa G; De Hoffer L; Nicolini L; Prinapori R; Bruzzone B
J Prev Med Hyg; 2013 Jun; 54(2):83-6. PubMed ID: 24396987
[TBL] [Abstract][Full Text] [Related]
13. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A
Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059
[TBL] [Abstract][Full Text] [Related]
14. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.
Fathy MM; Abo Taleb ME; El Hawary MS; Nabih MI; Aref WM; Makhlouf MM
Cytokine; 2015 Aug; 74(2):268-72. PubMed ID: 26003758
[TBL] [Abstract][Full Text] [Related]
15. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
16. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.
Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; García-Álvarez M; Resino S
BMC Med; 2013 Jan; 11():6. PubMed ID: 23298311
[TBL] [Abstract][Full Text] [Related]
18. Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review.
Shaheen M; Afzal S; Khubaib B; Amin I; Shahid M; Idrees M
Crit Rev Eukaryot Gene Expr; 2020; 30(3):223-229. PubMed ID: 32749108
[TBL] [Abstract][Full Text] [Related]
19. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
Shi X; Pan Y; Wang M; Wang D; Li W; Jiang T; Zhang P; Chi X; Jiang Y; Gao Y; Zhong J; Sun B; Xu D; Jiang J; Niu J
PLoS One; 2012; 7(5):e37054. PubMed ID: 22649509
[TBL] [Abstract][Full Text] [Related]
20. Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance.
Asthana M; Sahu SK; Kumar A; Mohanty S; Chakrabarti S; Das P; Chattopadhya NR; Chatterjee K; Singh SP; Rajasubramaniam S; Choudhuri T
Curr Drug Metab; 2018; 19(3):215-223. PubMed ID: 29380700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]